Enokizumab

Enokizumab ?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target IL9
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
ATC code None
UNII I4BE5F78HR Y
Chemical data
Formula C6492H10000N1704O2038S44 
Mol. mass 148.4 kDa
 N(what is this?)  (verify)

Enokizumab is a humanized monoclonal antibody designed for the treatment of asthma.[1]

Enokizumab was developed by MedImmune.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Enokizumab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/enokizumab.pdf. 
Immune system ("-l(i[m])-")
Human ("-limu-")
Mouse ("-limo-")
Chimeric ("-lixi-")
Humanized ("-lizu-")
Chimeric + humanized
("-lixizu-")
Interleukin ("-k(i[n])-")
Human ("-kinu-")
Humanized ("-kizu-", "-kinzu-")
Anrukinzumab • Enokizumab • Gevokizumab • Ixekizumab • Lebrikizumab • Olokizumab
Inflammatory lesions ("-les-")
Mouse ("-leso-")

M: LMC

cell/phys/auag/auab/comp, igrc

imdf/ipig/hyps/tumr

proc, drug(L3/4)